Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Calcineurin/Nfat signaling is required for perinatal lung maturation and function
Vrushank Davé, … , Gerald R. Crabtree, Jeffrey A. Whitsett
Vrushank Davé, … , Gerald R. Crabtree, Jeffrey A. Whitsett
Published October 2, 2006
Citation Information: J Clin Invest. 2006;116(10):2597-2609. https://doi.org/10.1172/JCI27331.
View: Text | PDF
Research Article Pulmonology

Calcineurin/Nfat signaling is required for perinatal lung maturation and function

  • Text
  • PDF
Abstract

Pulmonary surfactant proteins and lipids are required for lung function after birth. Lung immaturity and resultant surfactant deficiency cause respiratory distress syndrome, a common disorder contributing to morbidity and mortality in preterm infants. Surfactant synthesis increases prior to birth in association with formation of the alveoli that mediate efficient gas exchange. To identify mechanisms controlling perinatal lung maturation, the Calcineurin b1 (Cnb1) gene was deleted in the respiratory epithelium of the fetal mouse. Deletion of Cnb1 caused respiratory failure after birth and inhibited the structural maturation of the peripheral lung. Synthesis of surfactant and a lamellar body–associated protein, ABC transporter A3 (ABCA3), was decreased prior to birth. Nuclear factor of activated T cells (Nfat) calcineurin-dependent 3 (Nfatc3), a transcription factor modulated by calcineurin, was identified as a direct activator of Sftpa, Sftpb, Sftpc, Abca3, Foxa1, and Foxa2 genes. The calcineurin/Nfat pathway controls the morphologic maturation of lungs prior to birth and regulates expression of genes involved in surfactant homeostasis that are critical for adaptation to air breathing.

Authors

Vrushank Davé, Tawanna Childs, Yan Xu, Machiko Ikegami, Valérie Besnard, Yutaka Maeda, Susan E. Wert, Joel R. Neilson, Gerald R. Crabtree, Jeffrey A. Whitsett

×

Figure 5

The Abca3 gene is regulated by the Cn/Nfat pathway.

Options: View larger image (or click on image) Download as PowerPoint
The Abca3 gene is regulated by the Cn/Nfat pathway.
               
(A) ...
(A) Immunostaining of ABCA3 was decreased in respiratory epithelial tubules of Cnb1Δ/Δ mice at E18.5. Scale bars: 100 μm. (B) Consensus Nfat sites were detected in the Abca3 gene promoter. (C) The Abca3 gene promoter was activated by Nfatc3 and TTF-1. CA-Nfatc3 expression vector (0, 1, 2, and 3 μg) cotransfected with Abca3 promoter-luciferase constructs (1 μg; see Supplemental Table 1) in MLE-15 cells increased luciferase activity. TTF-1 (1 μg) and Nfatc3 (2 μg) expression synergistically activated the Abca3 gene promoter (1 μg) in HeLa cells, and expression of VIVIT (0, 0.08, 0.16, and 0.32 μg) inhibited transcription from Abca3 promoter constructs (0.25 μg) in MLE-15 cells. (D) EMSA with sites II and III of the Abca3 promoter and proteins in MLE-15 cell nuclear extracts. DNA-protein complexes formed with each site that was competed by 100-fold excess of unlabeled self DNA (lanes 5 and 12) but not by 100-fold excess of TTF-1 consensus probe (lanes 4 and 11). A consensus Nfat site from the IL-2 promoter competed for complex formation with both sites (lanes 3 and 10). Antibodies to Nfatc3 supershifted DNA-protein complexes formed on both sites (lanes 6 and 13). Free DNA probes containing NFAT site (lanes 1 and 8). MLE–nuclear extract (MLE-NE) bound to NFAT site DNA probes (lanes 2 and 9). BSA incubated with MLE-NE and NFAT site DNA probes (lanes 7 and 14).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts